ZXJ-89520-40811
4 vaccinations
8 coded responses
48 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 982 / WA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Moderna
-
2021-04-01
Registered in v-safe
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain, SwellingFree text: Vaccine site 2 inch radius from shot is warmer than the rest of my armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: 4 inch diameter around shot location warmer than rest of armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
-
2021-04-09
Health check-in — day 7, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-04-16
- 2021-04-21
-
2021-04-28
Dose 2 — Moderna
-
2021-04-28
Survey response — day 0, dose 2MedDRA: Injection site warmth — Feeling: Good · Site: Pain, SwellingFree text: Injection site feels warmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Injection site warmth, Insomnia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Insomnia, warm at injection site, loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · None · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia, Telemedicine — Feeling: Poor · Fever · None · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Telehealth Nurse Consultation about whether a fever should last so long. She said symptoms can last a week or more. It is not unusual. Im still concerned.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · None · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
-
2021-06-03
Survey response — day 35, dose 2MedDRA: Erythema, Pruritus — Feeling: GoodFree text: Skin slightly itchy and a few red spotsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-11
- 2021-07-28
-
2021-10-29
Dose 3 — Moderna
- 2021-10-29
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Pollakiuria — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Excessive urinationMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
- 2022-04-15
-
2022-04-22
Call successfulCompleted over the phone
-
2022-05-01
Survey response — 6 months, dose 3MedDRA: Alopecia, Influenza — Feeling: Fair · Be unable to work or attend schoolFree text: Had the flu. Still have some hair and eyelash thinningMedDRA releases: 2024-11 · check-in free text available
-
2022-08-13
Dose 4 — Moderna
- 2022-08-15
- 2022-08-18
- 2022-08-19
- 2022-08-20
- 2022-08-27
- 2022-09-03
- 2022-09-10
- 2022-09-17
- 2022-09-24
- 2022-11-12
- 2023-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Moderna | |
| 2 | 2021-04-28 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-08-13 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
1 wait over 3 months for a first call
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Vaccine site 2 inch radius from shot is warmer than the rest of my arm
Systemic reaction (other): 4 inch diameter around shot location warmer than rest of arm
Release 8 — day 0, dose 2
Systemic reaction (other): Injection site feels warm
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia, warm at injection site, loss of appetite
Healthcare visit (other): Telehealth Nurse Consultation about whether a fever should last so long. She said symptoms can last a week or more. It is not unusual. Im still concerned.
Release 8 — day 35, dose 2
Symptoms: Skin slightly itchy and a few red spots
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Excessive urination
Release 11 — 6 months, dose 3
Symptoms: Had the flu. Still have some hair and eyelash thinning
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Pyrexia | ✓ | ✓ | ✓ |
| HCVO | Telemedicine | ✓ | ✓ | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Pollakiuria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release